Bacterial infection alone not an indicator of poor lung function in...
Children with cystic fibrosis (CF) who have poor lung function early in life are more likely also to have poor lung function in adolescence, regardless of whether they are exposed to a common infection...
View ArticleInvasive diagnostic procedure for children with cystic fibrosis does not...
Compared to a standard diagnostic procedure, infants with cystic fibrosis who received treatment based on a diagnostic procedure involving obtaining and culturing fluid samples from the lungs did not...
View ArticleDrug-resistant bacteria top agenda of medical convention
The emergence of bacteria resistant to antibiotics and efforts by scientists trying to cope with the problem top the agenda at a medical convention under way here this weekend.
View ArticleStudy proves new technology kills bacteria
Results from a comprehensive multi-site clinical trial demonstrated that the use of antimicrobial copper surfaces in intensive care unit rooms reduced the amount of bacteria in the rooms by 97 percent...
View ArticleAn antibiotic effect minus resistance
After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery...
View ArticleTargeting bacterial gas defenses allow for increased efficacy of numerous...
Although scientists have known for centuries that many bacteria produce hydrogen sulfide (H2S) it was thought to be simply a toxic by-product of cellular activity. Now, researchers at NYU School of...
View ArticleEarly cystic fibrosis lung disease detected by bronchoalveolar lavage and...
The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.
View ArticleNew automated system to kill bacteria in hospital water systems and taps
A team of Trinity College Dublin researchers has developed a fully automated system that eradicates bacterial contamination in hospital water tanks, distribution systems and taps. This type of...
View ArticleParallel evolution - cystic fibrosis
(Medical Xpress) -- Researchers at the University of Liverpool are examining the evolution of Pseudomonas aeruginosa over time in the lungs of ten people with cystic fibrosis to understand why it...
View ArticleClinical trial to test success of Cystic Fibrosis lung infection treatment
Experts from Bristol and Nottingham are leading a major new national study to investigate whether intravenous antibiotics are effective in killing a common germ that causes dangerous complications in...
View Article'Resuscitating' antibiotics to overcome drug resistance
Combining common antibiotics with additional compounds could make previously resistant bacteria more susceptible to the same antibiotics. 'Resuscitation' of existing antibiotics has the potential to...
View ArticleP. aeruginosa bacteria associated with increased hospitalizations in COPD...
Patients with chronic obstructive pulmonary disease (COPD) who become infected with the bacterium Pseudomonas aerguinosa are more likely to have worse clinical outcomes and experience more...
View ArticleHealthy lungs' microbes focus of study on cystic fibrosis
(Medical Xpress)—Healthy people's lungs are home to a diverse community of microbes that differs markedly from the bacteria found in the lungs of cystic fibrosis patients. That's the result of new...
View ArticleNew plasma jet gives 'cold' shoulder to 'superbugs'
Scientists at Queen's University Belfast have developed a new technique which has the potential to kill off hospital superbugs like Pseudomonas aeruginosa, C. difficile and MRSA.
View ArticleUltrasound gel and infections: Researchers propose guidelines to reduce risk
In the December issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, guidelines have been proposed by epidemiologists from Beaumont...
View ArticleScientists discover potential new target in fight against 'superbug'
University of Cambridge researchers have discovered how an antibiotic-resistant superbug exploits oxygen-limited conditions in the lungs of patients with severe respiratory disease to thrive.
View ArticleInhaler approved for cystic fibrosis patients
(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a...
View ArticleAntibiotic may provide benefit for treatment of respiratory disorder
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic...
View ArticleA worm's-eye view of immunity
In 1998, scientists published the first complete genome of a multicellular organism—the worm Caenorhabditis elegans. At the same time, new technologies were emerging to help researchers manipulate...
View ArticleTarget two forms of iron to control cystic fibrosis lung infection
The bacterium Pseudomonas aeruginosa needs iron to establish and maintain a biofilm in the lungs of cystic fibrosis patients, and therapies have been proposed to deprive the bacteria of this necessary...
View Article
More Pages to Explore .....